EGFR and malignant colon neoplasm: Evidence for cooperativity was found in functional experiments when HT and cetuximab combination (10 μM and 1 μg/ml respectively), produced greater EGFR signaling impairment than that elicited by the single agents in the colon cancer cells examined (HT-29 and WiDr).